Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Hepatitis Virus and Hepatocellular Carcinoma: Recent Advances
Chen Shen, Xin Jiang, Mei Li, et al.
Cancers (2023) Vol. 15, Iss. 2, pp. 533-533
Open Access | Times Cited: 74

Showing 26-50 of 74 citing articles:

Taxifolin regulates SLC31A1-mediated cuproptosis and tumor progression in hepatocellular carcinoma
Jike Li, Yuelian Wang, Lei Bao, et al.
Human Cell (2025) Vol. 38, Iss. 2
Closed Access
The potential of epigallocatechin gallate in the chemoprevention and therapy of hepatocellular carcinoma
Dongming Li, Donghui Cao, Yingnan Cui, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 10
Precision targeting in hepatocellular carcinoma: Exploring ligand-receptor mediated nanotherapy
Xiaqing Zhou, Yaping Li, Shuangsuo Dang
World Journal of Hepatology (2024) Vol. 16, Iss. 2, pp. 164-176
Open Access | Times Cited: 3
The multifaceted role of PCSK9 in cancer pathogenesis, tumor immunity, and immunotherapy
Chou‐Yi Hsu, Mustafa Nasrat Abdulrahim, Mohammed Ahmed Mustafa, et al.
Medical Oncology (2024) Vol. 41, Iss. 8
Closed Access | Times Cited: 3
Nitidine chloride inhibits G2/M phase by regulating the p53/14-3-3 Sigma/CDK1 axis for hepatocellular carcinoma treatment
Bo Zhang, Bo Zhou, Guihong Huang, et al.
Heliyon (2024) Vol. 10, Iss. 1, pp. e24012-e24012
Open Access | Times Cited: 2
Integration of meta-analysis and network pharmacology analysis to investigate the pharmacological mechanisms of traditional Chinese medicine in the treatment of hepatocellular carcinoma
Jie Lin, Huaijuan Guo, Hanjiao Qin, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 2
NFKBIZ regulates NFκB signaling pathway to mediate tumorigenesis and metastasis of hepatocellular carcinoma by direct interaction with TRIM16
D. Guo, Ming Zhang, Tingju Wei, et al.
Cellular and Molecular Life Sciences (2024) Vol. 81, Iss. 1
Open Access | Times Cited: 2
Advancements in Immunotherapeutic Treatments for Hepatocellular Carcinoma: Potential of Combination Therapies
Yusra Zarlashat, Hafiz Salman Mushtaq, Linh Pham, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 13, pp. 6830-6830
Open Access | Times Cited: 2
Don’t fear the reaper: The role of regulated cell death in tumorigenesis and BH3-mimetics for cancer therapy
John E. La Marca, Gemma L. Kelly, Andreas Strasser, et al.
Developmental Cell (2024) Vol. 59, Iss. 19, pp. 2532-2548
Open Access | Times Cited: 2
Microbiome Differences in Colorectal Cancer Patients and Healthy Individuals: Implications for Vaccine Antigen Discovery
Gordon C. Ibeanu, Adekunle Babajide Rowaiye, Joel Okoli, et al.
ImmunoTargets and Therapy (2024) Vol. Volume 13, pp. 749-774
Open Access | Times Cited: 2
Diagnostic and Prognostic Nomograms for Hepatocellular Carcinoma Based on PIVKA-II and Serum Biomarkers
Shu An, Xiaoxia Zhan, Min Liu, et al.
Diagnostics (2023) Vol. 13, Iss. 8, pp. 1442-1442
Open Access | Times Cited: 5
Hepatitis E virus infection and risk of hepatocellular carcinoma: A systematic review and meta-analysis
Xia Yin, Fanggong Kan
Cancer Epidemiology (2023) Vol. 87, pp. 102457-102457
Closed Access | Times Cited: 5
Hepatitis B Virus and microRNAs: A Bioinformatics Approach
Verdiana Zulian, Giulia Fiscon, Paola Paci, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 24, pp. 17224-17224
Open Access | Times Cited: 5
Mechanism-guided fine-tuned microbiome potentiates anti-tumor immunity in HCC
Tao Liu, Ya Guo, Yanxia Liao, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 5
Synergistic Nanomedicine: Photodynamic, Photothermal and Photoimmune Therapy in Hepatocellular Carcinoma: Fulfilling the Myth of Prometheus?
Laura Marinela Ailioaie, Constantin Ailioaie, Gerhard Litscher
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 9, pp. 8308-8308
Open Access | Times Cited: 4
Viral hepatitis increases the risk of cholangiocarcinoma: a systematic review and meta-analysis
Bin Lin, Qiongxiao He, Yidan Lu, et al.
Translational Cancer Research (2023) Vol. 12, Iss. 6, pp. 1602-1616
Open Access | Times Cited: 4
Past, present, and future of chemically induced hepatocarcinogenesis rodent models: Perspectives concerning classic and new cancer hallmarks
Guilherme Ribeiro Romualdo, Renato Heidor, Gabriel Bacil Prata, et al.
Life Sciences (2023) Vol. 330, pp. 121994-121994
Closed Access | Times Cited: 4
Network-base approaches to identify therapeutic biomarkers in hepatocellular carcinoma and search for drug hunting utilizing molecular dynamics simulations
Hassan Ayaz, Faisal Ahmad, Sajjad Ahmad, et al.
Journal of Biomolecular Structure and Dynamics (2024), pp. 1-17
Closed Access | Times Cited: 1
The downregulation of Tapasin in dendritic cell regulates CD8+ T cell autophagy to hamper hepatitis B viral clearance in the induced pluripotent stem cell‐derived hepatocyte organoid
Jinmei Chen, Leer Shen, Qingxin Guo, et al.
Journal of Medical Virology (2024) Vol. 96, Iss. 3
Closed Access | Times Cited: 1
Progression of liver disease and associated risk of hepatocellular carcinoma
Edoardo Poli, Eléonora De Martin
Hepatoma Research (2024)
Open Access | Times Cited: 1
Exploring in vitro modeling in hepatocarcinogenesis research: morphological and molecular features and similarities to the corresponding human disease
Letícia Cardoso Valente, Gabriel Bacil Prata, Luana Riechelmann-Casarin, et al.
Life Sciences (2024) Vol. 351, pp. 122781-122781
Closed Access | Times Cited: 1
Bioinformatics analysis of the association between obesity and gastric cancer
Xiaole Ma, Miao Cui, Yuntong Guo
Frontiers in Genetics (2024) Vol. 15
Open Access | Times Cited: 1
HCV- and HBV-mediated liver cancer converge on similar transcriptomic landscapes and immune profiles.
Elizabeth S. Borden, A. Jørgensen, Heini M. Natri, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Comprehensive RNA-Seq Gene Co-Expression Analysis Reveals Consistent Molecular Pathways in Hepatocellular Carcinoma across Diverse Risk Factors
Nicholas Dale D. Talubo, Po‐Wei Tsai, Lemmuel L. Tayo
Biology (2024) Vol. 13, Iss. 10, pp. 765-765
Open Access | Times Cited: 1
Prediction model of hepatocellular carcinoma development in chronic hepatitis B virus infection in Spanish cohort
Paula Gavilán, Juan Carlos Orosco Gavilán, Rocío Arnedo, et al.
Medicina Clínica (2024) Vol. 163, Iss. 12, pp. 609-616
Closed Access | Times Cited: 1

Scroll to top